Skip to main content
. 2009 Mar 31;58(6):1419–1427. doi: 10.2337/db08-1792

TABLE 2.

Kinetic characteristics of glucokinase ins454A, W99L, and M197I

Mutants Yield (mg/l) kcat(sec−1) Glucose S0.5(mmol/l) ATP Km(mmol/l) nH(Hill number) Activity index Activation by GKA (fold) EC50for GKA (μmol/l)
ins454A 10.9 ± 3.1 53.2 ± 2.9 1.1 ± 0.1 0.3 1.2 39.5 ± 1.7 No activation N/A
W99L 19.9 ± 1.7 85.6 ± 3.1 2.9 ± 0.1 0.4 1.6 13.3 ± 0.8 11.8 4.3
M197I 62.1 ± 0.3 38.1 ± 4.5 2.6 ± 0.2 1.5 1.6 4.8 ± 0.3 11.9 4.9
M197L 34.5 54.5 5.4 1.0 1.4 3.8 13.9 6.2
M197V 25.1 44.7 2.6 0.5 1.7 8.0 13.1 3.5
M197A 36.4 53.3 3.2 0.3 1.7 7.0 14.7 3.8
M197T 26.7 53.9 4.1 0.5 1.6 4.4 18.3 5.5
M197F 40.3 21.2 54.6 0.2 1.3 0.1 8.6 6.1
M197K 36.4 3.78 86.7 0.2 1.1 0.03 13.6 9.3
M197D 27.7 10.3 197.0 0.3 1.1 0.03 6.0 2.8
M197E 6.82 21.0 56.2 1.3 0.2 0.1 9.0 2.7
Wild type 43.4 ± 3.8 62.3 ± 4.8 7.6 ± 0.2 0.4 1.7 1.5 ± 0.1 15.8 ± 0.6 6.9 ± 0.4

Kinetic data of purified expressed GST-tagged glucokinase with hyperinsulinism-causing ins454A (child 1), W99L (child 2), and M197I (child 3) mutations. EC50relates to the activity index. GKA, glucokinase activator; EC50, half-maximal effective concentration.

HHS Vulnerability Disclosure